Medtronic to Announce Financial Results for Its Second Quarter of Fiscal Year 2025
Medtronic, Recor Medical Score Renal Denervation Reimbursement Wins
Connected Drug Delivery Devices Market Forecast Report to 2035, Profiling Leading Companies Bigfoot Biomedical, BIOCORP, Eitan Medical, EoFlow, Insulet, Medtronic, Medtrum, Sonceboz, Ypsomed & More - ResearchAndMarkets.com
Press Releases
Medtronic (MDT) Outperforms Broader Market: What You Need to Know
Express News | CMS Grants Transitional Pass-Through Payment for Medtronic Symplicity Spyral™ Renal Denervation Catheter
CMS Grants Transitional Pass-Through Payment for Medtronic Symplicity Spyral Renal Denervation Catheter
Wound Care Industry Trends and Growth Opportunities, 2024-2029: A Forecasted $56.7 Billion Market Assessment With Exclusive Data on 60+ Companies - 3M, Braun, Cardinal Health, Convatec, Medtronic & More
Wells Fargo Maintains Medtronic(MDT.US) With Buy Rating, Maintains Target Price $106
Shares Of Boston Scientific See Volume; Company To Provide Cardiology Business Update At 4:00 PM EDT
Positive Trial Data on Symplicity RDN System Likely to Support MDT Stock
MedLumics New CEO and Board Member Announces 10 Patients Treated in First in Man (FIM) Clinical Trial With the Real-Time Visually Guided AblaView PFA System
Medtronic (MDT) Ascends But Remains Behind Market: Some Facts to Note
Medtronic Announces Long-Term Data From Its SPYRAL HTN-ON MED Clinical Trial That Showed Subjects Who Underwent Radiofrequency Renal Denervation With The Symplicity Spyral Renal Denervation System Had Greater Reductions In 24-Hr ABPM, And OSBP...
Express News | Spyral Htn-on Med Study Shows Significant, Consistent, Long-Term Blood Pressure Lowering Effect at Two Years
SPYRAL HTN-ON MED Study Shows Significant, Consistent, Long-term Blood Pressure Lowering Effect at Two Years
Internet of Medical Things (IoMT) Market Report 2024-2034, Featuring Profiles of Baxter, Bio Techne, Biotronik, Boston Scientific, Cisco Systems, GE Healthcare, IBM, Medtronic, Siemens and More
Medtronic's (NYSE:MDT) Returns Have Hit A Wall
Medtronic Analyst Ratings
Apple Reportedly Tests a Blood Sugar App